{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:26:52Z","timestamp":1791966412631,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R21HD109616"],"award-info":[{"award-number":["1R21HD109616"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R56MH128365"],"award-info":[{"award-number":["R56MH128365"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21MH128827"],"award-info":[{"award-number":["R21MH128827"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES033636"],"award-info":[{"award-number":["R01ES033636"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acetaminophen (APAP) is the most widely used analgesic during pregnancy, yet its effects on prenatal human brain development remain incompletely understood. Epidemiological studies have reported inconsistent associations between prenatal APAP exposure and later neurodevelopmental outcomes, underscoring the need for mechanistic evaluation in human-relevant developmental models. Here, we examined how APAP influences early cortical development using induced pluripotent stem cell-derived cortical organoids (COs) generated from six independent lines. Organoids were exposed to physiologically relevant APAP concentrations (25, 50, and 100\u2009\u03bcM) for 5 days beginning at day 21 of differentiation, corresponding to late first-trimester cortical development. We assessed organoid growth, apoptosis, differentiation, synaptic maturation, transcriptomic profiles using bulk and single-nucleus RNA sequencing (snRNA-seq), and functional network activity using multielectrode array recordings up to 4 months. APAP exposure did not affect organoid size, cytoarchitecture, or viability. Neuronal and progenitor cell proportions, as well as synaptic puncta density were unchanged. Bulk RNA-seq revealed subtle transcriptional changes only at the highest dose (16 differentially expressed genes at 100\u2009\u03bcM), enriched for neurodevelopmental pathways. In contrast, snRNA-seq at 3 months revealed no changes in cell type composition or gene expression. Consistent with the limited molecular changes observed, electrophysiological measures including firing rate, burst frequency, and network synchrony, showed no significant differences from controls. Together, these results indicate that direct exposure to parent APAP at the concentrations tested produces minimal molecular perturbations. These findings reflect responses to parent acetaminophen in vitro and do not exclude metabolite-mediated or systemic effects in vivo.<\/jats:p>","DOI":"10.1038\/s41380-026-03920-w","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:28:57Z","timestamp":1791289737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acetaminophen produces limited molecular and functional effects in human cortical organoids"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-3776","authenticated-orcid":false,"given":"Luca","family":"Trov\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9637-9066","authenticated-orcid":false,"given":"George","family":"Kucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gimena","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaina Sena","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0867-2875","authenticated-orcid":false,"given":"Alysson R.","family":"Muotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4542-5219","authenticated-orcid":false,"given":"Lilia M.","family":"Iakoucheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"3920_CR1","doi-asserted-by":"publisher","first-page":"e004365","DOI":"10.1136\/bmjopen-2013-004365","volume":"4","author":"A Lupattelli","year":"2014","unstructured":"Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, M\u00e5rdby AC, Moretti ME, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4:e004365.","journal-title":"BMJ Open"},{"key":"3920_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","volume":"193","author":"MM Werler","year":"2005","unstructured":"Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193:771\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"3920_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","volume":"12","author":"A Bertolini","year":"2006","unstructured":"Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12:250\u201375.","journal-title":"CNS Drug Rev"},{"key":"3920_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","volume":"21","author":"GG Graham","year":"2013","unstructured":"Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: Therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21:201\u201332.","journal-title":"Inflammopharmacology"},{"key":"3920_CR5","doi-asserted-by":"crossref","unstructured":"Levy G, Garrettson L, Soda D. Letter: Evidence of Placental Transfer of Acetaminophen.\u00a0Pediatrics. 1985;55:895.","DOI":"10.1542\/peds.55.6.895"},{"key":"3920_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1542\/peds.2006-3378","volume":"119","author":"E Kumpulainen","year":"2007","unstructured":"Kumpulainen E, Kokki H, Halonen T, Heikkinen M, Savolainen J, Laisalmi M. Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration. Pediatrics. 2007;119:766\u201371.","journal-title":"Pediatrics"},{"key":"3920_CR7","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/ije\/dyt183","volume":"42","author":"RE Brandlistuen","year":"2013","unstructured":"Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013;42:1702\u201313.","journal-title":"Int J Epidemiol"},{"key":"3920_CR8","doi-asserted-by":"publisher","first-page":"20163840","DOI":"10.1542\/peds.2016-3840","volume":"140","author":"E Ystrom","year":"2017","unstructured":"Ystrom E, Gustavson K, Brandlistuen RE, Knudsen GP, Magnus P, Susser E, et al. Prenatal exposure to acetaminophen and risk of ADHD. PEDIATRICS. 2017;140:20163840\u201320163840.","journal-title":"PEDIATRICS"},{"key":"3920_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/EDE.0000000000000540","volume":"27","author":"Z Liew","year":"2016","unstructured":"Liew Z, Ritz B, Virk J, Arah OA, Olsen J. Prenatal use of acetaminophen and child IQ: a danish cohort study. Epidemiology. 2016;27:912\u20138.","journal-title":"Epidemiology"},{"key":"3920_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","volume":"168","author":"Z Liew","year":"2014","unstructured":"Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168:313\u201320.","journal-title":"JAMA Pediatr"},{"key":"3920_CR11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/aje\/kwy086","volume":"187","author":"R Masarwa","year":"2018","unstructured":"Masarwa R, Levine H, Gorelik E, Reif S, Perlman A, Matok I. Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review,meta-analysis, and meta-regression analysis of cohort studies. Am J Epidemiol. 2018;187:1817\u201327.","journal-title":"Am J Epidemiol"},{"key":"3920_CR12","doi-asserted-by":"crossref","unstructured":"Bauer AZ, Kriebel D, Herbert MR, Bornehag CG, Swan SH. Prenatal paracetamol exposure and child neurodevelopment: a review. Horm Behav. 2018;101:125\u201347.","DOI":"10.1016\/j.yhbeh.2018.01.003"},{"key":"3920_CR13","doi-asserted-by":"crossref","unstructured":"Olsen J, Liew Z. Fetal programming of mental health by acetaminophen? Response to the SMFM statement: prenatal acetaminophen use and ADHD. Expert Opin Drug Saf. 2017;16:1395\u201398.","DOI":"10.1080\/14740338.2017.1384812"},{"key":"3920_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/mp.2017.119","volume":"23","author":"M Hornig","year":"2018","unstructured":"Hornig M, Bresnahan MA, Che X, Schultz AF, Ukaigwe JE, Eddy ML, et al. Prenatal fever and autism risk. Mol Psychiatry. 2018;23:759\u201366.","journal-title":"Mol Psychiatry"},{"key":"3920_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/oxfordjournals.aje.a114131","volume":"122","author":"S Greenland","year":"1985","unstructured":"Greenland S, Robins JM. Confounding and misclassification. Am J Epidemiol. 1985;122:495\u2013506.","journal-title":"Am J Epidemiol"},{"key":"3920_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/pds.3300","volume":"22","author":"RG Radin","year":"2013","unstructured":"Radin RG, Mitchell AA, Werler MM. Predictors of recall certainty of dates of analgesic medication use in pregnancy. Pharmacoepidemiol Drug Saf. 2013;22:25\u201332.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3920_CR17","doi-asserted-by":"crossref","unstructured":"Gustavson K, Ystrom E, Ask H, Ask Torvik F, Hornig M, Susser E et al. Acetaminophen use during pregnancy and offspring attention deficit hyperactivity disorder \u2013 a longitudinal sibling control study. JCPP Adv 2021; 1:e12020.","DOI":"10.1002\/jcv2.12020"},{"key":"3920_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jama.2024.3172","volume":"331","author":"VH Ahlqvist","year":"2024","unstructured":"Ahlqvist VH, Sj\u00f6qvist H, Dalman C, Karlsson H, Stephansson O, Johansson S, et al. Acetaminophen use during pregnancy and children\u2019s risk of autism, ADHD, and intellectual disability. JAMA. 2024;331:1205\u201314.","journal-title":"JAMA"},{"key":"3920_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jamapediatrics.2026.0071","volume":"180","author":"PC Lee","year":"2026","unstructured":"Lee PC, Chuang YH, Hu YH, Lin CN, Li CY, Chen YY, et al. Maternal acetaminophen use and child neurodevelopment. JAMA Pediatr. 2026;180:527\u201334.","journal-title":"JAMA Pediatr"},{"key":"3920_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0015360","volume":"5","author":"I Posadas","year":"2010","unstructured":"Posadas I, Santos P, Blanco A, Mu\u00f1oz-Fern\u00e1ndez M, Ce\u00f1a V. Acetaminophen induces apoptosis in rat cortical neurons. PLoS ONE. 2010;5:1\u201314.","journal-title":"PLoS ONE"},{"key":"3920_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/toxsci\/kft329","volume":"138","author":"H Viberg","year":"2014","unstructured":"Viberg H, Eriksson P, Gordh T, Fredriksson A. Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice. Toxicological Sci. 2014;138:139\u201347.","journal-title":"Toxicological Sci"},{"key":"3920_CR22","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/molecules26071845","volume":"26","author":"S Schultz","year":"2021","unstructured":"Schultz S, Gould GG, Antonucci N, Brigida AL, Siniscalco D. Endocannabinoid system dysregulation from acetaminophen use may lead to autism spectrum disorder: Could cannabinoid treatment be efficacious? Molecules. 2021;26:1845.\u00a0","journal-title":"Molecules"},{"issue":"5 SPEC. ISS.","key":"3920_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.neuro.2007.01.014","volume":"28","author":"B Clancy","year":"2007","unstructured":"Clancy B, Finlay BL, Darlington RB, Anand KJS. Extrapolating brain development from experimental species to humans. NeuroToxicology. 2007;28(5 SPEC. ISS.):931\u20137.","journal-title":"NeuroToxicology"},{"key":"3920_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/toxsci\/kfaa136","volume":"178","author":"AM Tukker","year":"2020","unstructured":"Tukker AM, Wijnolts FMJ, de Groot A, Westerink RHS. Applicability of hiPSC-Derived neuronal cocultures and rodent primary cortical cultures for in vitro seizure liability assessment. Toxicol Sci. 2020;178:71\u201387.","journal-title":"Toxicol Sci"},{"key":"3920_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/toxsci\/kfw147","volume":"154","author":"JP Brown","year":"2016","unstructured":"Brown JP, Hall D, Frank CL, Wallace K, Mundy WR, Shafer TJ. Editor\u2019s highlight: evaluation of a microelectrode array-based assay for neural network ontogeny using training set chemicals. Toxicol Sci. 2016;154:126\u201339.","journal-title":"Toxicol Sci"},{"key":"3920_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/cells12060958","volume":"12","author":"HR Lu","year":"2023","unstructured":"Lu HR, Seo M, Kreir M, Tanaka T, Yamoto R, Altrocchi C, et al. High-throughput screening assay for detecting drug-induced changes in synchronized neuronal oscillations and potential seizure risk based on Ca(2+) fluorescence measurements in human induced pluripotent stem cell (hiPSC)-Derived neuronal 2D and 3D Cultures. Cells. 2023;12:958.","journal-title":"Cells"},{"key":"3920_CR27","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/s00204-025-04043-x","volume":"99","author":"KE Carstens","year":"2025","unstructured":"Carstens KE, Gronskaya E, Jackel D, Bertoli J, Cuevas KR, Dorier J, et al. Application of a high-density microelectrode array assay using a 3D human iPSC-derived brain microphysiological system model for in vitro neurotoxicity screening of environmental compounds. Arch Toxicol. 2025;99:2917\u201335.","journal-title":"Arch Toxicol"},{"key":"3920_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.cell.2013.10.020","volume":"155","author":"AJ Willsey","year":"2013","unstructured":"Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell. 2013;155:997\u20131007.","journal-title":"Cell"},{"key":"3920_CR29","doi-asserted-by":"publisher","first-page":"eaat7615","DOI":"10.1126\/science.aat7615","volume":"362","author":"M Li","year":"2018","unstructured":"Li M, Santpere G, Imamura Kawasawa Y, Evgrafov OV, Gulden FO, Pochareddy S, et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science. 2018;362:eaat7615.","journal-title":"Science"},{"key":"3920_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1126\/science.aav8130","volume":"364","author":"D Velmeshev","year":"2019","unstructured":"Velmeshev D, Schirmer L, Jung D, Haeussler M, Perez Y, Mayer S, et al. Single-cell genomics identifies cell type-specific molecular changes in autism. Science. 2019;364:685\u20139.","journal-title":"Science"},{"key":"3920_CR31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41593-024-01624-4","volume":"27","author":"R Dear","year":"2024","unstructured":"Dear R, Wagstyl K, Seidlitz J, Markello RD, Arnatkeviciute A, Anderson KM, et al. Cortical gene expression architecture links healthy neurodevelopment to the imaging, transcriptomics and genetics of autism and schizophrenia. Nat Neurosci. 2024;27:1075\u201386.","journal-title":"Nat Neurosci"},{"key":"3920_CR32","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.cell.2013.10.031","volume":"155","author":"NN Parikshak","year":"2013","unstructured":"Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell. 2013;155:1008\u201321.","journal-title":"Cell"},{"key":"3920_CR33","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41588-022-01104-0","volume":"54","author":"JM Fu","year":"2022","unstructured":"Fu JM, Satterstrom FK, Peng M, Brand H, Collins RL, Dong S, et al. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat Genet. 2022;54:1320\u201331.","journal-title":"Nat Genet"},{"key":"3920_CR34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.aad6469","volume":"359","author":"MJ Gandal","year":"2018","unstructured":"Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359:693\u20137.","journal-title":"Science"},{"key":"3920_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2015.01.010","volume":"85","author":"GN Lin","year":"2015","unstructured":"Lin GN, Corominas R, Lemmens I, Yang X, Tavernier J, Hill DE, et al. Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases. Neuron. 2015;85:742\u201354.","journal-title":"Neuron"},{"key":"3920_CR36","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.1038\/s41380-021-01243-6","volume":"26","author":"J Urresti","year":"2021","unstructured":"Urresti J, Zhang P, Moran-Losada P, Yu NK, Negraes PD, Trujillo CA, et al. Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism. Mol Psychiatry. 2021;26:7560\u201380.","journal-title":"Mol Psychiatry"},{"key":"3920_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.stem.2019.08.002","volume":"25","author":"CA Trujillo","year":"2019","unstructured":"Trujillo CA, Gao R, Negraes PD, Gu J, Buchanan J, Preissl S, et al. Complex oscillatory waves emerging from cortical organoids model early human brain network development. Cell Stem Cell. 2019;25:558\u2013569.e557.","journal-title":"Cell Stem Cell"},{"key":"3920_CR38","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1038\/s41596-024-00994-0","volume":"19","author":"MQ Fitzgerald","year":"2024","unstructured":"Fitzgerald MQ, Chu T, Puppo F, Blanch R, Chill\u00f3n M, Subramaniam S, et al. Generation of \u2018semi-guided\u2019 cortical organoids with complex neural oscillations. Nat Protoc. 2024;19:2712\u201338.","journal-title":"Nat Protoc"},{"key":"3920_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2015.06.034","volume":"162","author":"J Mariani","year":"2015","unstructured":"Mariani J, Coppola G, Zhang P, Abyzov A, Provini L, Tomasini L, et al. FOXG1-Dependent dysregulation of GABA\/Glutamate neuron differentiation in autism spectrum disorders. Cell. 2015;162:375\u201390.","journal-title":"Cell"},{"key":"3920_CR40","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41380-022-01862-7","volume":"28","author":"JW Adams","year":"2023","unstructured":"Adams JW, Negraes PD, Truong J, Tran T, Szeto RA, Guerra BS, et al. Impact of alcohol exposure on neural development and network formation in human cortical organoids. Mol Psychiatry. 2023;28:1571\u201384.","journal-title":"Mol Psychiatry"},{"key":"3920_CR41","doi-asserted-by":"publisher","first-page":"eabe8244","DOI":"10.1126\/science.abe8244","volume":"375","author":"N Caporale","year":"2022","unstructured":"Caporale N, Leemans M, Birgersson L, Germain PL, Cheroni C, Borb\u00e9ly G, et al. From cohorts to molecules: adverse impacts of endocrine disrupting mixtures. Science. 2022;375:eabe8244.","journal-title":"Science"},{"key":"3920_CR42","doi-asserted-by":"publisher","first-page":"eaat8127","DOI":"10.1126\/science.aat8127","volume":"362","author":"MJ Gandal","year":"2018","unstructured":"Gandal MJ, Zhang P, Hadjimichael E, Walker RL, Chen C, Liu S, et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science. 2018;362:eaat8127.","journal-title":"Science"},{"key":"3920_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40261-017-0610-4","volume":"38","author":"RB Raffa","year":"2018","unstructured":"Raffa RB, Pawasauskas J, Pergolizzi JV, Lu L, Chen Y, Wu S, et al. Pharmacokinetics of oral and intravenous paracetamol (Acetaminophen) when co-administered with intravenous morphine in healthy adult subjects. Clin Drug Investig. 2018;38:259\u201368.","journal-title":"Clin Drug Investig"},{"key":"3920_CR44","first-page":"e80","volume":"2","author":"XL Jiang","year":"2013","unstructured":"Jiang XL, Zhao P, Barrett JS, Lesko LJ, Schmidt S. Original article: Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children. CPT: Pharmacomet Syst Pharmacol. 2013;2:e80.","journal-title":"CPT: Pharmacomet Syst Pharmacol"},{"key":"3920_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40262-019-00799-5","volume":"59","author":"P Mian","year":"2020","unstructured":"Mian P, van den Anker JN, van Calsteren K, Annaert P, Tibboel D, Pfister M, et al. Physiologically based pharmacokinetic modeling to characterize acetaminophen pharmacokinetics and N-Acetyl-p-Benzoquinone imine (NAPQI) formation in non-pregnant and pregnant women. Clin Pharmacokinetics. 2020;59:97\u2013110.","journal-title":"Clin Pharmacokinetics"},{"key":"3920_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.biopsych.2018.02.1176","volume":"84","author":"S Martin-Brevet","year":"2018","unstructured":"Martin-Brevet S, Rodr\u00edguez-Herreros B, Nielsen JA, Moreau C, Modenato C, Maillard AM, et al. Quantifying the effects of 16p11.2 copy number variants on brain structure: a multisite genetic-first study. Biol Psychiatry. 2018;84:253\u201364.","journal-title":"Biol Psychiatry"},{"key":"3920_CR47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41380-018-0118-1","volume":"25","author":"S\u00f8nderby","year":"2020","unstructured":"S\u00f8nderby, G\u00fastafsson IE, Doan NT \u00d3, Hibar DP, Martin-Brevet S, Abdellaoui A, et al. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia. Mol Psychiatry. 2020;25:584\u2013602.","journal-title":"Mol Psychiatry"},{"key":"3920_CR48","doi-asserted-by":"crossref","unstructured":"Turrigiano GG, Nelson SB Homeostatic plasticity in the developing nervous system. Nat Rev Neurosci. 2004;5:97\u2013107.","DOI":"10.1038\/nrn1327"},{"key":"3920_CR49","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature10523","volume":"478","author":"HJ Kang","year":"2011","unstructured":"Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, et al. Spatio-temporal transcriptome of the human brain. Nature. 2011;478:483\u20139.","journal-title":"Nature"},{"key":"3920_CR50","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","volume":"30","author":"MR McGill","year":"2013","unstructured":"McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013;30:2174\u201387.","journal-title":"Pharm Res"},{"key":"3920_CR51","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pharmthera.2008.02.005","volume":"118","author":"RN Hines","year":"2008","unstructured":"Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther. 2008;118:250\u201367.","journal-title":"Pharmacol Ther"},{"key":"3920_CR52","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1432-1033.1996.0476z.x","volume":"238","author":"I Vieira","year":"1996","unstructured":"Vieira I, Sonnier M, Cresteil T. Developmental expression of CYP2E1 in the human liver Hypermethylation control of gene expression during the neonatal period. Eur J Biochem. 1996;238:476\u201383.","journal-title":"Eur J Biochem"},{"key":"3920_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00228-003-0622-2","volume":"59","author":"CD Van Der Marel","year":"2003","unstructured":"Van Der Marel CD, Anderson BJ, Pluim MAL, De Jong THR, Gonzalez A, Tibboel D. Acetaminophen in cerebrospinal fluid in children. Eur J Clin Pharmacol. 2003;59:297\u2013302.","journal-title":"Eur J Clin Pharmacol"},{"key":"3920_CR54","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1038\/s41380-021-01104-2","volume":"26","author":"PD Negraes","year":"2021","unstructured":"Negraes PD, Trujillo CA, Yu NK, Wu W, Yao H, Liang N, et al. Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy. Mol Psychiatry. 2021;26:7047\u201368.","journal-title":"Mol Psychiatry"},{"key":"3920_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09915","volume":"473","author":"KJ Brennand","year":"2011","unstructured":"Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473:221\u20135.","journal-title":"Nature"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03920-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:28:59Z","timestamp":1791289739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03920-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":55,"alternative-id":["3920"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03920-w","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Muotri is the co-founder of and has an equity interest in TISMOO, a company dedicated to genetic analysis and human brain organogenesis, focusing on therapeutic applications customized to autism spectrum disorders and other neurological diseases. Muotri holds several patents related to stem cells and brain organoid models. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies. Other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Human iPSC lines used in this study were derived from previously established control lines described in prior publications. The derivation and use of these lines were approved by the University of California San Diego Institutional Review Board and Embryonic Stem Cell Research Oversight (IRB\/ESCRO) Committee, and informed consent was obtained from the donors from whom the original cells were derived. All experiments involving human iPSCs were conducted in accordance with relevant institutional guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}